about
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)P62: An emerging oncotarget for osteolytic metastasisA comparative study between limb-salvage and amputation for treating osteosarcomaIncidence of pain flare in radiation treatment of bone metastases: A literature reviewAnti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesOsteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature reviewOsteochondromyxoma: Review of a rare carney complex criterionReceptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersQuality of life after palliative radiotherapy in bone metastases: A literature reviewThe role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasisEfficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesionsThe chordoma arised from ilium: A rare case report.Postoperative complications with cryotherapy in bone tumors.Clinical characteristics and risk factors analysis of lung metastasis of benign giant cell tumor of bone.Schwannoma of the femur: A rare case reportAssessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreUse of urinary markers in cancer setting: A literature reviewIncreased Insulin mRNA Binding Protein-3 Expression Correlates with Vascular Enhancement of Renal Cell Carcinoma by Intravenous Contrast-CT and is Associated with Bone Metastasis.The unresolved role of systemic factors in bone metastasis.A definition of "uncomplicated bone metastases" based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapyGorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid.Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meetingSocioeconomic and demographic factors contributing to outcomes in patients with primary lymphoma of bone.Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-studyDiagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patientsThe role of 18F-NaF PET/CT in metastatic bone diseaseDosing of zoledronic acid with its anti-tumor effects in breast cancer.Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcomaIncidence of distal bone metastases in patients treated for palliative radiotherapy and associations with primary tumour types.Utility of opposed-phase magnetic resonance imaging in differentiating sarcoma from benign bone lesions.Surface osteosarcoma: Clinical features and therapeutic implications.Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trialRadiofrequency ablation in experimental bone metastases using a controlled and navigated ablation deviceAdjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?Evidence-based guidelines: Improving AGREEment on consistence evaluationThe Italian cross-sectional survey of the management of bone metastasis: ZeTa study.A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts.Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro.
P1433
Q26747566-C4BDD704-5C57-4DE8-BC4B-1FD3B1A903BCQ26753091-18D76E90-6BD9-49D2-A41B-81CDBCD60380Q26753095-0EDE31FA-69E1-4741-AD38-5166D39897D8Q26823213-192C8A77-9604-41E8-BD1E-1EE11343EDE3Q26863493-658D9FD2-A602-48A1-B795-A703F25383F2Q27008336-8A530635-E319-405F-A74E-E5836042CA35Q28073245-3340FF03-2C6A-4714-8150-AE1A50ABB95CQ28082793-62361542-E32C-4357-97F0-0B52223B75FBQ28083440-922C85A0-6E63-4E0A-945A-51FA48EA1F79Q28597660-40499B93-5572-41BC-B584-7DC84EB0B95FQ31048683-56F5808D-20A7-489E-8EFF-A07E916D9672Q33275852-5C6981C6-7009-4BA9-8563-EEFFE32C7A44Q33561538-D99F5052-D2FA-4312-9311-A63262EDCCB4Q33581569-C28D95CF-E01F-400D-B97A-CABFF625B2F8Q33736277-3F32241E-C64B-4FAF-9702-86C1638B2A7AQ33792517-015A6681-C945-4092-9E0C-0A50537A62C3Q35844765-8EAD8FAE-40B0-4B23-8913-E76668E02F62Q36165534-57757979-3BB9-4676-8D24-6C4FAFF78790Q36168514-8C4150D1-F648-427D-977F-6AD41FBB3992Q36207581-20F148B6-4E3A-49B0-85E5-21B27B6E5CB3Q36207586-C6DE690C-4996-4BB5-AC05-34477B9109E5Q36207662-486B635B-3833-4869-91B6-D5DBABB64630Q36207667-242AFFC9-0777-4FA7-AD22-29E94EAA4F24Q36207673-906B9C52-949B-4589-B2C8-3C27E91E766CQ36289997-B0F94154-E2AC-4B16-B845-C95BD9802CBDQ36290002-B252BAFE-854E-41DA-9800-833B3DC29966Q36290007-AD64FB15-149D-40A4-8164-3BB26C590AD6Q36290012-C6B2EF7C-6A3F-4BB4-845B-3AF9EF44C11EQ36370722-D5750B25-C9FE-402E-9ED1-655C2BF32D99Q36370734-25488986-62E6-495C-B1BE-619780874753Q36370755-7DEEA121-6A4E-4CE4-92A4-5FAD25EA9DFEQ36491348-DF614135-4CEB-4286-8FA0-5D6FD08696E3Q36491353-3BD723D7-D0CD-4EBE-8E7C-56FBDDDD6C21Q36491357-5A403F24-7535-403A-8F7E-C5B054EA5052Q36491364-CF47C430-F40F-442C-BC29-D979ACD37BE8Q36491369-A5ECA380-4D41-4D52-8C0B-6D89C133E57DQ36491373-0FFD697E-6CAA-4D10-B0DF-5092A11F7982Q36491378-8E5D4FFF-FBF0-4B65-913B-395936D3E5E4Q36491383-C3BAEE68-8060-4B83-93EB-12A53E49138AQ36491391-CC27D80F-B396-45B6-8643-5479C383EDEB
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of bone oncology
@ast
Journal of bone oncology
@en
Journal of bone oncology
@es
Journal of bone oncology
@it
Journal of bone oncology
@nl
type
label
Journal of bone oncology
@ast
Journal of bone oncology
@en
Journal of bone oncology
@es
Journal of bone oncology
@it
Journal of bone oncology
@nl
altLabel
Journal of Bone Oncology
@en
prefLabel
Journal of bone oncology
@ast
Journal of bone oncology
@en
Journal of bone oncology
@es
Journal of bone oncology
@it
Journal of bone oncology
@nl
P31
P1055
P1156
21100206283
P123
P1250
P1277
P236
P5115
P5963
journal-of-bone-oncology